Home > Official notices > Statutory Committee inquiries  |  Search

The Pharmaceutical Journal
Vol 273 No 7329 p870
11 December 2004


Statutory Committee inquiries

The Statutory Committee will meet at the Royal Pharmaceutical Society of Great Britain, 1 Lambeth High Street, London SE1, at 9.30am on Monday 13 December, Tuesday 14 December and Wednesday 15 December 2004 to hear the following inquiries:

Monday 13 December
1. The Committee hopes to deliver its decision in an inquiry into a complaint by the Council of the Society against two pharmacists and a company which alleges that various failings in relation to the manufacture and preparation of products, storing of raw materials, product labelling, and the recording and custody of controlled drugs may amount to misconduct. This inquiry was adjourned from 24 November 2004.

2. The Committee will resume its inquiry into a complaint by the Council of the Society against a pharmacist which alleges that a failure to honour an agreement to provide locum services and informing a pharmacy manager that he was unable to work because of illness when he had arranged to work as a locum and did work at another pharmacy on the day in question may amount to misconduct.

3. An inquiry into a complaint by the Council of the Society against a pharmacist which alleges that obtaining medicines for onward supply to the public from a source other than a manufacturer or licensed wholesaler and failing to take appropriate steps to check that the source, supplier and quality of those medicines was reputable may amount to misconduct.

Tuesday 14 December
4. An inquiry into the case of a pharmacist convicted of conspiracy to steal.

5. An inquiry into the case of a pharmacist convicted of theft.

Wednesday 15 December
6. An inquiry into a complaint by the Council of the Society against a pharmacist which alleges that the unlawful supply of a prescription-only medicine in the absence of a prescription by a member of pharmacy staff while the pharmacist was the pharmacist in charge may amount to misconduct.

David Gomez
Secretary to the Statutory Committee

Back to Top


©The Pharmaceutical Journal